Your browser doesn't support javascript.
loading
Establishment of cell-lines stably expressing recombinant Japanese eel follicle-stimulating hormone and luteinizing hormone using CHO-DG44 cells: fully induced ovarian development at different modes.
Kazeto, Yukinori; Ito, Risa; Tanaka, Toshiomi; Suzuki, Hiroshi; Ozaki, Yuichi; Okuzawa, Koichi; Gen, Koichiro.
Afiliação
  • Kazeto Y; Fisheries Technology Institute, Minamiizu Field Station, Japan Fisheries Research and Education Agency, Minamiizu, Shizuoka, Japan.
  • Ito R; Fisheries Technology Institute, Tamaki Field Station, Japan Fisheries Research and Education Agency, Tamaki, Mie, Japan.
  • Tanaka T; Hamanako Branch, Shizuoka Prefectural Research Institute of Fishery and Ocean, Hamamatsu, Shizuoka, Japan.
  • Suzuki H; Fisheries Technology Institute, Shibushi Field Station, Japan Fisheries Research and Education Agency, Shibushi, Kagoshima, Japan.
  • Ozaki Y; Fisheries Technology Institute, Tamaki Field Station, Japan Fisheries Research and Education Agency, Tamaki, Mie, Japan.
  • Okuzawa K; Fisheries Technology Institute, Tamaki Field Station, Japan Fisheries Research and Education Agency, Tamaki, Mie, Japan.
  • Gen K; Fisheries Technology Institute, Nagasaki Station, Japan Fisheries Research and Education Agency, Nagasaki, Japan.
Front Endocrinol (Lausanne) ; 14: 1201250, 2023.
Article em En | MEDLINE | ID: mdl-37693354
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Hormônio Luteinizante / Hormônio Foliculoestimulante Humano Limite: Animals Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Hormônio Luteinizante / Hormônio Foliculoestimulante Humano Limite: Animals Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão